Answers are grounded in this paper and cite their sources.
Different treatment strategies may be indicated for intermediate-risk versus moderately high- or high-risk patients based on differential survival rates and rates of relapse. Use of trimodality treatment for all patients with intermediate-risk lesions may be excessive, since S plus CT resulted in 5-year OS of approximately 85%; however, 5-year disease-free survival rates with S plus CT were 78% (T1-2/N1) and 69%(T3/N0), indicating room for improvement.
No takes yet. Share an insight, caveat, or question.
Gunderson et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: